Fox Chase hosts third International Inflammatory Breast Cancer Conference

November 30, 2012

PHILADELPHIA, PA (November 30, 2012)--Fox Chase Cancer Center will host the Third International Inflammatory Breast Cancer Conference on December 1-2, 2012, at the Sofitel Philadelphia (120 South 17th Street, Philadelphia).

The conference will focus on educating healthcare professionals and breast cancer advocates about inflammatory breast cancer (IBC)--a rare and very aggressive form of the disease that accounts for 1 to 5 percent of all breast cancers.

The driving force behind this unique international conference is the collaboration between co-director's Massimo Cristofanilli, MD, Professor of Medicine at Fox Chase's Department of Medical Oncology, and Kenneth van Golen, PhD, Associate Professor in the Department of Biological Sciences at the University of Delaware. Cristofanilli's long-standing expertise in treating patients with inflammatory breast cancer, along with van Golen's well-established laboratory research on the disease makes them an ideal team to lead this conference.

The conference will commence with an opening ceremony on Saturday, December 1, 2012, at 5:00 p.m. ET. Presentations at the conference will focus on the following topics:
Committee members for the 2012 Inflammatory Breast Cancer Conference, include: Pam Alizadeh, RN, Onc NP, MS, AOCN, CBCN, MD Anderson Cancer Center; Professor Francois Bertucci, MD, PhD, Institu Paoli-Calmettes; Melissa Bondy, PhD, Baylor College of Medicine; Patti Bradfield, Inflammatory Breast Cancer Foundation DBA and Erase IBC Foundation; Bernadette Ciukurescu, BSN, RN-BC, Fox Chase Cancer Center; Gayathri Devi, PhD, Duke University; Luc Y. Dirix, MD, Sint-Augustinus Hospital; Valerie Fraser, IBC Survivor/Research Advocate, Michigan Breast Cancer Coalition; Julia Goplerud, BSJ, MA, Fox Chase Cancer Center; Paul H. Levine, MD, George Washington University School of Public Health and Health Services; Ginny Mason, RN, BSN, Inflammatory Breast Cancer Research Foundation; Bonnie Miller, RN, BSN, OCN, FAAMA, Fox Chase Cancer Center; Margaret O'Grady, RN, MSN, OCN, FAAMA, Fox Chase Cancer Center; Fredika M. Robertson, PhD, MD Anderson Cancer Center; Kathy Smith, CMP, CCMEP, Fox Chase Cancer Center; Amr Soliman, MD, PhD, University of Nebraska Medical Center; Kathy Truesdale, AS, BA, Fox Chase Cancer Center; Naoto T. Ueno, MD, PhD, FACP, MD Anderson Cancer Center; Prof. Steven Van Laere, PhD, Sint-Augustinus Hospital; Peter B. Vermeulen, MD, PhD, Sint-Augustinus Hospital; Patrice Viens, MD, Institu Paoli-Calmettes; Kendra V. Woods, PhD, MD Anderson Cancer Center.

Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation's first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center's nursing program has received the Magnet status for excellence three consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, visit Fox Chase's Web site at or call 1-888-FOX CHASE or (1-888-369-2427).

Fox Chase Cancer Center

Related Disease Articles from Brightsurf:

CLCN6 identified as disease gene for a severe form of lysosomal neurodegenerative disease
A mutation in the CLCN6 gene is associated with a novel, particularly severe neurodegenerative disorder.

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

Potential link for Alzheimer's disease and common brain disease that mimics its symptoms
A new study by investigators from Brigham and Women's Hospital uncovered a group of closely related genes that may capture molecular links between Alzheimer's disease and Limbic-predominant Age-related TDP-43 Encephalopathy, or LATE, a recently recognized common brain disorder that can mimic Alzheimer's symptoms.

Antioxidant agent may prevent chronic kidney disease and Parkinson's disease
Researchers from Osaka University developed a novel dietary silicon-based antioxidant agent with renoprotective and neuroprotective effects.

Tools used to study human disease reveal coral disease risk factors
In a study published in Scientific Reports, a team of international researchers led by University of Hawai'i (UH) at Mānoa postdoctoral fellow Jamie Caldwell used a statistical technique typically employed in human epidemiology to determine the ecological risk factors affecting the prevalence of two coral diseases--growth anomalies, abnormalities like coral tumors, and white syndromes, infectious diseases similar to flesh eating bacteria.

Disease-aggravating mutation found in a mouse model of neonatal mitochondrial disease
The new mitochondrial DNA (mtDNA) variant drastically speeds up the disease progression in a mouse model of GRACILE syndrome.

Human longevity largest study of its kind shows early detection of disease & disease risks
Human Longevity, Inc. (HLI) announced the publication of a ground-breaking study in the journal Proceedings of the National Academy of Sciences (PNAS).

30-year study identifies need of disease-modifying therapies for maple syrup urine disease
A new study analyzes 30 years of patient data and details the clinical course of 184 individuals with genetically diverse forms of Maple Syrup Urine Disease (MSUD), which is among the most volatile and dangerous inherited metabolic disorders.

Long-dormant disease becomes most dominant foliar disease in New York onion crops
Until recently, Stemphylium leaf blight has been considered a minor foliar disease as it has not done much damage in New York since the early 1990s.

Read More: Disease News and Disease Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to